Compounds > ondansetron
Page last updated: 2024-11-01

ondansetron and Diarrheogenic Islet Cell Tumor

ondansetron has been researched along with Diarrheogenic Islet Cell Tumor in 1 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Delahunt, JW1
Burgess, C1
Bott, V1

Other Studies

1 other study available for ondansetron and Diarrheogenic Islet Cell Tumor

ArticleYear
Ondansetron and VIPoma.
    The New Zealand medical journal, 1993, Jun-23, Volume: 106, Issue:958

    Topics: Adult; Humans; Male; Nausea; Ondansetron; Pancreatic Neoplasms; Vipoma

1993